V-Wave

V-Wave™ Ventura Interatrial Shunt | VWaveMedical.com

Headquarters: Caesarea
Employees: 51–200
Founded: 2009
Business Model: B2B

Website: vwavemedical.com
Total Funding: $196.0M
Last Round: $98.0M Series CDec 2021
Rounds: 3

About

V-Wave developed the Ventura Interatrial Shunt for chronic heart failure. Founded Israel 2009, FDA Breakthrough Device, CE Marking. Acquired by J&J MedTech Oct 2024.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Series CSeries CDec 2021

Dec 2021

V-Wave

About

Tech & App Stack

Sign up to view funding chart

Funding History

Investors

Sign up to view investors

Similar Companies